Clinical Trial Update: Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Istalol 0.5% once daily with Brimonidine tartrate 0.1% twice daily as add-on therapy to latanoprost in adults with ocular hypertension o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• BRIMONIDINE TARTRATE (brimonidine tartrate)
• ISTALOL (Timolol maleate)
• Latanoprost (Latanoprost)

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Ocular Hypertension, Open-Angle Glaucoma | Phase 4 | Status: COMPLETED